U.S. Approves Drug That Can Sharply Lower Cholesterol Levels
Friday, July 24, 2015 - 19:30
in Health & Medicine
The drug, Praluent, developed by Sanofi and Regeneron, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical price.